Clinical Trials Browser

Observational × HER2-positive Breast Cancer × Trastuzumab × Clear all

NCT03738553 2025-10-29

Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy

Active not recruiting

HER2-positive Breast Cancer